Discovering a Common Goal,
Discovering a Cure

CONTACT  |  DONATE  |  E-NEWSLETTER  | 
  
DRUG NEWS

Research News
Drug News
Conference News
< Home



Fast-Track Designation Granted to NurOwn for Treating ALS
October 17, 2014
The U.S. Food and Drug Administration (FDA) has granted Fast-Track designation to BrainStorm Cell Therapeutics’ NurOwn for treating ALS. The company’s stem cell therapy consist...

Human Placental Cells Safe for Treating Multiple Sclerosis
October 17, 2014
In a first-of-its-kind study, a stem cell therapy consisting of human placenta-derived stromal cells was shown to be safe in multiple sclerosis (MS) patients. The Phase 1b study of...

New DoD Initiative Aims at Improving Success of Traumatic Brain Injury Clinical Trials
October 17, 2014
Athletes who suffer repeated head injuries are at significantly higher risk of developing neurodegenerative diseases later in life than the general population, with a reported 3-fo...

NeuroLINCS Program Established to Create Database of Human Neuronal Signatures
October 17, 2014
The University of California, Irvine (UCI) received an $8M award from the NIH to establish and spearhead a Library of Integrate Network-Based Cellular Signatures (LINCS) program fo...

NIH Awards $46 Million as Part of the BRAIN Initiative
October 2, 2014
The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, launched by President Obama last year, is a large scale effort to advance our understanding of...





The ALS Forum was developed by Prize4Life, Inc.
 
© 2014 Prize4Life, Inc.
Identified content provided through
a partnership with the Alzforum